Geron Stock Price To Book
| GERN Stock | USD 1.75 0.05 2.94% |
Geron fundamentals help investors to digest information that contributes to Geron's financial success or failures. It also enables traders to predict the movement of Geron Stock. The fundamental analysis module provides a way to measure Geron's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Geron stock.
As of the 21st of March 2025, Price To Book Ratio is likely to grow to 8.57. Geron | Price To Book |
Geron Company Price To Book Analysis
Geron's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Geron Price To Book | 3.93 X |
Most of Geron's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Geron is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Geron Price To Book Driver Correlations
Understanding the fundamental principles of building solid financial models for Geron is extremely important. It helps to project a fair market value of Geron Stock properly, considering its historical fundamentals such as Price To Book. Since Geron's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Geron's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Geron's interrelated accounts and indicators.
Click cells to compare fundamentals
Geron Price To Book Historical Pattern
Today, most investors in Geron Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Geron's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to book growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Geron price to book as a starting point in their analysis.
Geron Price To Book |
| Timeline |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Geron Book Value Per Share
Book Value Per Share |
|
Based on the latest financial disclosure, Geron has a Price To Book of 3.9307 times. This is 84.69% lower than that of the Biotechnology sector and 34.92% lower than that of the Health Care industry. The price to book for all United States stocks is 58.67% higher than that of the company.
Geron Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Geron's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Geron could also be used in its relative valuation, which is a method of valuing Geron by comparing valuation metrics of similar companies.Geron is currently under evaluation in price to book category among its peers.
Geron Current Valuation Drivers
We derive many important indicators used in calculating different scores of Geron from analyzing Geron's financial statements. These drivers represent accounts that assess Geron's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Geron's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 431.6M | 399.7M | 921.5M | 1.2B | 2.3B | 2.4B | |
| Enterprise Value | 451.1M | 419.8M | 920.0M | 1.2B | 2.2B | 2.3B |
Geron Fundamentals
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.22 | ||||
| Profit Margin | (2.27) % | ||||
| Operating Margin | (0.42) % | ||||
| Current Valuation | 816.99 M | ||||
| Shares Outstanding | 636.9 M | ||||
| Shares Owned By Institutions | 78.41 % | ||||
| Number Of Shares Shorted | 69.77 M | ||||
| Price To Earning | (12.48) X | ||||
| Price To Book | 3.93 X | ||||
| Price To Sales | 14.06 X | ||||
| Revenue | 76.99 M | ||||
| Gross Profit | (28 M) | ||||
| EBITDA | (154.85 M) | ||||
| Net Income | (174.57 M) | ||||
| Cash And Equivalents | 219.29 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 3.24 M | ||||
| Debt To Equity | 0.39 % | ||||
| Current Ratio | 4.85 X | ||||
| Book Value Per Share | 0.46 X | ||||
| Cash Flow From Operations | (218.62 M) | ||||
| Short Ratio | 3.32 X | ||||
| Earnings Per Share | (0.27) X | ||||
| Price To Earnings To Growth | (2.38) X | ||||
| Target Price | 4.5 | ||||
| Number Of Employees | 229 | ||||
| Beta | 0.53 | ||||
| Market Capitalization | 1.08 B | ||||
| Total Asset | 593.78 M | ||||
| Retained Earnings | (1.77 B) | ||||
| Working Capital | 402.69 M | ||||
| Current Asset | 115.89 M | ||||
| Current Liabilities | 6.63 M | ||||
| Net Asset | 593.78 M |
About Geron Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Geron's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Geron using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Geron based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock: Check out Geron Piotroski F Score and Geron Altman Z Score analysis. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.27) | Revenue Per Share | Quarterly Revenue Growth 2.1 K | Return On Assets | Return On Equity |
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.